Malignant catarrhal fever (MCF) is a severe, usually fatal, acute systemic disease syndrome of certain domestic and wild ruminants caused by members of the family Gammaherpesvirinae. Two distinct but closely related viruses cause clinically indistinguishable syndromes: one that is indigenous to the wildebeest and the other that apparently is indigenous to domestic sheep. Neither the pathogenesis nor the epidemiology of sheep-associated MCF (SA-MCF) is understood, primarily because of a lack of adequate detection methods for the etiologic agent or antibody against it. No acceptably documented isolates of SA-MCF virus have been reported, and existing antibody assays suffer from significant cross-reactivity with other viruses. As a basis for a specific serologic assay, an attempt was made to identify an epitope conserved among all isolates of MCF viruses, by using a monoclonal antibody (MAb) produced against a previously reported U.S. isolate of MCF virus. A MAb (15-A) which bound a conserved epitope present on all four isolates of MCF virus examined was found. MAb 15-A did not react with eight common sheep and goat viruses or five common bovine viruses. Immunoprecipitation revealed that the 15-A epitope was located on the viral glycoprotein complex, with molecular masses of 115, 110, 105, 78, and 45 kDa. Sera from experimentally and naturally infected animals which yielded a similar glycoprotein complex immunoprecipitation pattern competed with MAb 15-A for its epitope. A competitive inhibition enzyme-linked immunosorbent assay (ELISA) based on MAb 15-A was therefore developed. The assay detected antibody in inapparently infected sheep and in cattle, deer, and bison with clinical MCF. Of the 149 serum samples from sheep associated with MCF outbreaks, 88 (55%) were seropositive by competitive inhibition ELISA.
Malignant catarrhal fever (MCF) is a frequently fatal lymphoproliferative and inflammatory disease syndrome of certain domestic and wild ruminant species caused by closely related members of the family Gammaherpesvirinae (3). Two major epidemiologic forms of MCF, defined by the reservoir ruminant species from which the causative virus arises, are recognized. One, known as the African form, is referred to as wildebeest-associated MCF (4, 32, 33) . The etiology is a relatively well-characterized lymphotrophic gammaherpesvirus, named alcelaphine herpesvirus 1 (AHV-1) (37), which is indigenous in the wildebeest (subfamily Alcelaphinae) to which it is well adapted and nonpathogenic.
The other major, worldwide source of an MCF agent is thought to be domestic sheep. Though never successfully propagated in vitro, there is substantial epidemiologic and serologic evidence that a virus closely related to AHV-1 exists in sheep and is transmitted, often at lambing, to susceptible, poorly adapted ruminants such as domestic cattle, deer, and bison (29, 31, 35) . Sheep-associated malignant catarrhal fever (SA-MCF) is one of the few known infectious diseases for which an etiologic agent has never been isolated. Moreover, experimental transmission of MCF to cattle by inoculation of material from suspect sheep has been almost uniformly unsuccessful (8, 15 (18) , herpesvirus saimiri (9) , and Marek's disease virus (40) .
MCF usually is sporadic but occasionally occurs epizootically, causing significant losses (5, 28, 30, 36) . The lack of available confirmed sheep-associated isolates has hindered development of efficient reagents for diagnosis and control of SA-MCF. The identification of MCFV-infected sheep currently is based on the detection of antibodies to AHV-1, the wildebeest isolate (14, 26, 41) . Only low titers of neutralizing antibody to AHV-1 are found in infected sheep (11, 38) , limiting the utility of the neutralization test. Indirect immunofluorescence (IIF) and enzyme-linked immunosorbent assay (ELISA), using AHV-1-infected cells as antigens, are the tests currently in most common use (14, 38, 41) . Their accuracy is also limited, however, by the fact that MCFVs share antigens with other bovine herpesviruses (13, 23) . Thus, insensitivity and nonspecificity seriously limit the usefulness of the currently available tests for studying the epidemiology, pathogenesis, and control of SA-MCF (11, 12, 22 Table 2 ), diagnoses having been established by clinical signs and pathologic lesions. MCFV antibody-negative sheep sera were obtained from 5-to 6-month-old lambs in a local farm flock in Pullman, Wash. Antisera to MN-MCFV were raised in rabbits by immunization with MN-MCFV antigen prepared as described above. Rabbit antiserum against the WC-11 strain of AHV-1 was purchased from a commercial source (Cytimmune, San Diego, Calif.). Sera from naturally infected wildebeest and other exotic ruminants were supplied by W. Heuschele. Sera from sheep experimentally inoculated with a U.S. isolate of AHV-1 (4, 41) were kindly provided by A. Castro, Pennsylvania State University. Bovine antisera to MCFV 732, a putative SA-MCFV isolate from Austria (39), and to BHV-1, BHV-2, BHV-4, and bovine viral diarrhea virus were kindly provided by J. Pearson, National Veterinary Service Laboratory, USDA Animal and Plant Health Inspection Service, Ames, Iowa. Antisera to CAEV and OPPV were obtained from the Washington Animal Disease Diagnostic Laboratory, Pullman. Antisera to ovine herpesvirus 1 and caprine herpesvirus were raised in mice by inoculation of virus propagated on sheep kidney cells and purified by sucrose gradient centrifugation as described above.
Radioimmunoprecipitation. Radioimmunoprecipitation of labeled viral proteins was performed as previously described (20 Boston, Mass.) was added to the medium, and the cultures were harvested at 90% cytopathic effect. For radioimmunoprecipitation, labeled cell lysates were mixed with polyclonal antisera or monoclonal antibodies (MAbs), and the antigenantibody complexes were allowed to bind to recombinant protein G-coated beads (GENEX Co., Gaithersburg, Md.). The beads were then precipitated and washed, bound complexes were solubilized, and the solubilates were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. CI-ELISA. A panel of MAbs to MN-MCFV was produced and characterized as described elsewhere (21) . MAbs with high activity in ELISA were evaluated for their ability to compete for their epitopes with antibodies from sheep seropositive for MCFV as defined byIIF and radioimmunoprecipitation. Competitive inhibition ELISA (CI-ELISA) was performed by using a modification of a previously described procedure (1, 19) . Negative control sera were defined by an absence of MCFV antibody detectable by IIF and immunoprecipitation. When the mean of the three replicate OD readings of a serum was more than 3 standard deviations below the mean of a panel of six negative control serum samples, run in triplicate, the serum was considered positive for MCFV antibody.
RESULTS
Identification of an epitope conserved among isolates of MCFV. Sixty-four MAbs with high reactivity in ELISA were selected and tested against sheep sera by CI-ELISA. MAb 15-A was inhibited by sera from sheep that tested positive for MCFV antibody in IIF and immunoprecipitation. MAb 15-A of isotype immunoglobulin G2b, when used in immunoprecipitation, bound an epitope located on a glycoprotein complex which, on reducing gels, resolved into five bands with apparent molecular masses of 115, 110, 105, 78, and 45 kDa (Fig. 1A) . from the animals listed above that were positive for MCFV by immunoprecipitation were examined for their ability to block the binding of MAb 15-A in CI-ELISA. MAb 15-A was efficiently inhibited by antisera against a variety of MCFV isolates of both wildebeest and sheep origin but was not significantly inhibited by the preinoculation sera from the same animals or from other uninoculated control animals of the same species (Fig. 3) .
Specificity of MAb 15-A for MCFV. To provide evidence of
the specificity of MAb 15-A, rabbits were immunized by intramuscular injection with purified MN-MCFV with TiterMax adjuvant (Vaxcel, Inc., Norcross, Ga.) and tested for antibody by CI-ELISA. Sera from these rabbits competed effectively with MAb 15-A in CI-ELISA, in contrast to sera from the rabbit immunized with uninfected FMSK cell antigen (Fig. 4) . Moreover, sera from rabbits immunized with the WC-11 strain of AHV-1, from sheep inoculated with a U.S. isolate of AHV-1 (4, 43) , and a calf infected with a putative SA-MCFV isolate (MCFV 732) from Austria, which has recently been reported (39) , strongly competed with the MAb 15-A in CI-ELISA (Fig. 3) were positive by CI-ELISA, inhibiting the test by >3 standard deviations more than the mean inhibition value for the negative controls. All sera positive by CI-ELISA were also positive by IIF. The converse, however, was not true: some serum samples that were positive by IIF were negative by CI-ELISA (Table 2 ). Of 65 lambs tested that were less than 1 year old, only 2 were seropositive by CI-ELISA, whereas a high percentage of sheep over 1 year old were seropositive ( Table 3) . The test detected antibody in six of eight cows, two of three deer, and two bison with clinical MCF. The sensitivity of CI-ELISA was comparable to that of IIF. Antibody titers of sera from sheep experimentally infected with a U.S. isolate of AHV-1 (4, 41) as measured by the two assays were not significantly different (Fig. 5) . Moreover, when samples were compared at only a single dilution, the percentage inhibition in CI-ELISA was generally proportional to the immunofluorescent staining intensity (data not shown). Careful optimization of the coating antigen concentration significantly improved the sensitivity of the assay (data not shown). The concentration of the MAb, however, was less critical, suggesting that it might have a low binding affinity (16) . been shown with herpes simplex virus (42, 43) and human cytomegalovirus (17, 34) .
Two hundred forty-seven of 555 (44.55%) sheep serum samples collected from seven different states were positive by CI-ELISA. One hundred forty-nine of the 555 samples were from sheep known to have been associated with MCF outbreaks in cattle, deer, or bison. Eighty-eight of these 149 serum samples (55%) were positive. This relatively high percentage of seropositivity in sheep is consistent with earlier studies based on IIF and indirect ELISA, in which infection rates ranging from 22 to 97% were reported (22, 23, 38, 41) . The wide range may reflect differences in the ages of sheep examined, as well as the relatively low specificities of these assays. In the present study, a very low rate of seropositivity was present for lambs under 1 year of age. It was much higher for sheep 2 years of age and older. A better definition of the relationship between seropositivity and age requires examination of a larger set of sequentially collected samples, which is underway.
The pattern suggested by the data herein, perhaps surprisingly, contrasts with that which is usually seen in wildebeest calves infected with AHV-1, apparently at birth (25, 31) . The infected calves shed virus into the environment, serving as an important source of disease transmission (27) . Neutralizing antibody to AHV-1 is usually detectable in wildebeest calves by 3 months of age (24) , after which shedding ceases. The serological pattern in sheep suggested by this study is reminiscent, however, of that of natural infections of squirrel monkeys with herpesvirus saimiri, another gammaherpesvirus, wherein the young are infected not at birth but sometime after 12 months of age. By 2 years of age, virtually all young squirrel monkeys born of persistently infected mothers have seroconverted (6, 7) . Whether the pattern in sheep reflects delayed infection or a delayed immune response to an earlier infection remains to be determined.
Only limited numbers of serum samples were examined from other ruminant species, both domestic and wild. A seroprevalence rate generally resembling that found in domestic sheep was found in domestic goats and bighorn sheep. In contrast, other ruminant species, such as llamas and mountain goats, were found not to exhibit significant rates of seropositivity (data not shown). Preliminary studies have found significant concordance between CI-ELISA and detection of the agent by PCR, using primers derived from a recently reported sequence of an SA-MCFV-specific DNA fragment (2) . Studies to better define the epidemiologic patterns of this agent in various wild and domestic ruminant species are currently ongoing.
